HealingMaps

By Ketamine Articles ketamine therapy ketamine treatment psychedelics On July 13, 2026, the FDA finalized its first formal guidance for studying psychedelic drugs in people. The rules cover psilocybin, LSD, and MDMA. They do not cover ketamine. So a ketamine clinic owner could skim the headlines and move on. That would be a mistake. This guidance is the clearest signal yet that a new category of treatment is about to arrive, and ketamine clinics are the infrastructure best positioned to deliver it.

By Ketamine Articles ketamine therapy ketamine treatment The five Hartford-area rankings below draw on verified per-clinic detail from the HealingMaps directory; pricing benchmarks reflect our 2026 national dataset.

By Ibogaine Articles Ketamine Articles MDMA articles Psilocybin Articles psychedelics The FDA has finalized its first formal guidance for studying psychedelic drugs in people. The document landed on July 13, 2026, and it sets the ground rules for research into psilocybin, LSD, and MDMA. It began as a draft in June 2023. That draft then sat for nearly three years while stakeholder feedback went unanswered. A psychedelics executive order in April changed the pace overnight.

By Peptide Articles The most talked about peptides in America are not the best studied ones. BPC-157 dominates clinic menus and podcast conversations, yet it rests on only three small human studies. GHK-Cu, a copper binding peptide that far fewer clinics market well, carries the strongest body of human clinical evidence in the category. For a field fighting for medical credibility, that gap is worth promoting. Do you run a peptide clinic?

By GLP-1 Peptide Articles The FDA is not writing warning letters about the medicine in your GLP-1 program. It is writing them about the words on your website. In June 2026 the agency sent 25 warning letters to telehealth and compounding operations over false or misleading claims about compounded semaglutide, tirzepatide, and liraglutide. That followed more than 40 similar letters in late 2025 and over 50 in September 2025. The pattern is clear, and the trigger is copy, not chemistry.

By Anesthesiologist Ketamine Articles ketamine therapy ketamine treatment regulation texas The Texas Medical Board was expected to vote on its sweeping ketamine regulations in June. That vote never came. Instead, the board withdrew its original proposal, published a revised version in the May 15 Texas Register, and has now revised the rules again.

By Peptide Articles Everyone has an opinion about what peptide clinics offer. Almost no one has counted. We reviewed the published treatment menus of 846 verified peptide clinics across all 50 states to answer a simple question with data instead of anecdote. What does peptide medicine in America actually look like, one clinic menu at a time? The answer overturns the most common assumption in the field, one many clinic owners hold about their own industry.

By Ketamine Articles ketamine therapy ketamine treatment Pricing benchmarks in this guide reflect our 2026 national dataset; the eight Colorado Springs clinic rankings that follow draw on verified per-clinic detail from the HealingMaps directory. HealingMaps Original Research Colorado Springs is Colorado’s second-largest city and one of the most military-dense metros in the country, anchored by Fort Carson, Peterson and Schriever Space Force Bases, Cheyenne Mountain, and the Air Force Academy.

By Psilocybin Articles psychedelics Minnesota is moving closer to creating a regulated psilocybin therapy program, although legal access will not begin this year. Lawmakers approved a feasibility study that could shape a future system for supervised treatment. The Office of Cannabis Management must deliver its recommendations by January 15, 2027. New: Interested in Being Part of a Psychedelics-Focused Clinical Trial?

By Peptide Articles Every week, patients reach HealingMaps looking for a peptide clinic. They rarely ask in clinical language. They describe a torn shoulder that will not heal, a libido that has flattened, a weight loss drug they read about that no clinic seems to carry yet. Read enough of these inquiries and a clear map of real demand emerges, and it does not perfectly match what clinics put on their menus. The gap between the two is where the business opportunity lives.